Neumora Therapeutics NMRA
NASDAQ NMRA
$1.31 -0.04 (-2.96%)
At close: Sep 4, 2026 · 4:00 PM EDT

Neumora Therapeutics (NMRA) Interest Coverage Ratio (2025 - 2026)

Neumora Therapeutics (NMRA) posted quarterly Interest Coverage Ratio of 28.51 for Q1 2026, up 0.73% quarter-over-quarter from 28.72 in Q4 2025.

Analysis

Neumora Therapeutics (NMRA) Interest Coverage Ratio (2025 - 2026) Analysis & Trends

Neumora Therapeutics' Interest Coverage Ratio history runs 5 years deep, the most recent figure standing at 28.51 for Q1 2026.

  • In Q1 2026, Interest Coverage Ratio changed N/A year-over-year to 28.51; the TTM figure through Mar 2026 stood at 57.35 (changed N/A YoY), while the FY2025 annual figure was 0.73, up 26.71% from the prior year.
  • Interest Coverage Ratio for Q1 2026 stood at 28.51, up from 28.72 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 0.22 in Q4 2022, with the low at 57.7 in Q3 2025.
  • The 5-year median for Interest Coverage Ratio is 1.26 (2024), against an average of 16.85.
  • The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio sank 110.35% in 2024, then plunged 5392.29% in 2025.
  • Neumora Therapeutics' Interest Coverage Ratio stood at 0.22 in 2022, then plunged by 166.3% to 0.58 in 2023, then slumped by 81.8% to 1.05 in 2024, then slumped by 2634.05% to 28.72 in 2025, then increased by 0.73% to 28.51 in 2026.
  • Business Quant data shows NMRA's Interest Coverage Ratio at 28.51 in Q1 2026, 28.72 in Q4 2025, and 57.7 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 117.59
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -493.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -21.24
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.18
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2.82
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.42
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.08
10 Neumora Therapeutics 243.49 Mn 243.49 Mn - -23.18
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.18
Mar 31, 2026 -28.51
Dec 31, 2025 -28.72
Sep 30, 2025 -77.24
Jun 30, 2025 -123.94